YesChef Posted - 2 days ago

$EXEL Judge needs to hurry his a$$ up with the decision!

Stocksrunner Posted - 4 days ago

📈 Key Technical Indicators & Trends Unveiled: Chart Analysis! $MPC, $ALTO, $DIS, and $EXEL all enter oversold territory, indicating potential buying opportunities amidst selling pressure in the stock market.

erevnon Posted - 4 days ago

Stephens & Co. initiates coverage on Exelixis $EXEL at Equal-Weight and a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

Acwild70 Posted - 4 days ago

$EXEL they just keep shorting this down don’t they

1st_Base Posted - 1 week ago

$EXEL My EXEL friends, I received the invite for the forthcoming meeting. I suspect they want us to accept a RS. I'm against it. Because I think Management want it to keep getting their free shares without causing investor alarm. This would be due to the fact that Shares Outstanding would se low.

fda_tracker Posted - 1 week ago

$EXEL Phase 2 trial w/est May completion date NCT04289779: https://www.clinicaltrials.gov/study/NCT04289779 Trial Tracker: https://www.fdatracker.com/trial-tracker/

Bornjever Posted - 1 week ago

$EXEL company has outstanding sales and profits could improve but punishing a good company with profits since 2021 and tremendous pipeline is shortsighted.

ElijahJobs Posted - 1 week ago

$EXEL Is the fucking judge going to finally make the ruling? What an asshole. JMO

Acwild70 Posted - 1 week ago

$EXEL why the drop after hours?

DefenseMania Posted - 1 week ago

$EXEL $GILD who’s going to win the “2024 WORST CEO IN AMERICA “ award this year ? EXEL or GILD ?

UncleStock Posted - 2 weeks ago

$CORT $UTHR $INCY $EXEL suggested for $BTK US ARCA Biotechnology - value screen: https://zpr.io/tWJwE

ElijahJobs Posted - 2 weeks ago

$EXEL Sounded like when/if EXEL wins the patent case, there will be significant investment from BP... I still think BO is not ruled out. JMO "Third, final reply briefs for the second MSN ANDA trial were submitted in February and we continue to expect a ruling in the first half of 2024. While we will not speak to any specifics today, this remains a critical milestone for the company and the Cabozantinib franchise. Exelixis will continue to vigorously protect our intellectual property rights with respect to Cabo and our other differentiated molecules we pursue on behalf of patients with cancer. Finally, fourth, we expect business development activities to ramp up significantly as we gain clarity on the outcome of the patent litigation. Importantly, we're exploring options to collaborate with other organizations in cost and compound sharing arrangements in a manner similar to our prior Cabozantinib checkpoint combination endeavors."

ElijahJobs Posted - 2 weeks ago

$EXEL OK, so it will hover around at this level until the patent decision is made. I think that Cabometyx sales are already being impacted by expectation that it will lose some patent protection early? But the management seems to be somewhat confident since it kept the 2024 revenue projection? We will see. If/when EXEL wins all patent cases, it will be bought out, too, in perhaps mid-40's. JMO

Tangle22 Posted - 2 weeks ago

$EXEL 10% down is too much against Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update…!

DefenseMania Posted - 2 weeks ago

$RCUS $AMZN $PFE $EXEL $NVS

troy14 Posted - 2 weeks ago

$EXEL @DefenseMania And morons like you belong in a Special needs daycare center.

DefenseMania Posted - 2 weeks ago

$EXEL these guys belong in prison !!!!

ElijahJobs Posted - 04/30/24

$EXEL To me, they deserve all their stock based compensations IF and ONLY IF they have successfully protected the patents. If not, they deserve a very special place in h_ _ _. JMO

bioman4 Posted - 04/30/24

$EXEL maybe the execs won’t get options now for missing…

xbibackto70s Posted - 04/30/24

$EXEL bios+earnings=fun

DefenseMania Posted - 04/30/24

$EXEL boi Troy14 pump this POS up CEO IS THE WORST EVER !!!

ElijahJobs Posted - 04/30/24

$EXEL No mention of the patent ruling in the ER as far as I can see. Whatever. The lazy judge better get up on his ass and provide the ruling already.

Acwild70 Posted - 04/30/24

$EXEL oh no. The sky is falling!!! What an over reaction by the market !!!

Estimize Posted - 04/30/24

$EXEL misses the Estimize EPS Consensus by 11c and the Estimize Revenue Consensus by $39.69M. Reports FQ1 earnings of 17c EPS and $425.... http://www.estimize.com/exel/fq1-2024?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits

epsguid Posted - 04/30/24

$EXEL reported earnings of $0.12, consensus was $0.22 via @eWhispers #epsmiss http://eps.sh/d/exel

Stock_Titan Posted - 04/30/24

$EXEL Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update https://www.stocktitan.net/news/EXEL/exelixis-announces-first-quarter-2024-financial-results-and-provides-yxwb7ro1egze.html

Doozio Posted - 04/30/24

🐑 r still SKWD on this 1st pullback in 🧠⏰. ✍️ some lines throw some 🎯s n wUtch the 🧠 $exel on eps?

leonbnu Posted - 04/30/24

$EXEL earnings today, hope they will talk about the patent decision

Estimize Posted - 04/30/24

$EXEL reports after the close, Estimize Consensus -0 EPS and +3.87M Revs compared to WS http://www.estimize.com/exel/fq1-2024?utm_content=prerelease&utm_medium=tweet&utm_source=stocktwits

Discreetsuccess Posted - 04/30/24

$EXEL I voted